FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799290306> ?p ?o ?g. }

• W2799290306 endingPage "1350" @default.
• W2799290306 startingPage "1345" @default.
• W2799290306 abstract "We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were prospectively defined as frail using a simplified version of the Comprehensive Geriatric Assessment (CGA). Patients had to be over 70 years of age, with histologically confirmed DLBCL. Frail patients were those younger than 80 years with a frail profile at CGA or older than 80 years with an unfit profile. Treatment consisted of 4-6 courses of bendamustine [90 mg/m2 days (d)1-2] and rituximab (375 mg/m2 d1) administered every 28 days. Other main study end points were complete remission rate and the rate of extra-hematologic adverse events. Forty-nine patients were enrolled of whom 45 were confirmed eligible. Overall, 24 patients achieved a complete remission (53%; 95%CI: 38-68%) and the overall response rate was 62% (95%CI: 47-76%). The most frequent grade 3-4 adverse event was neutropenia (37.8%). Grade 3-4 extra-hematologic adverse events were observed in 7 patients (15.6%; 95%CI: 6.5-29.5%); the most frequent was grade 3 infection in 2 patients. With a median follow up of 33 months (range 1-52), the median progression-free survival was ten months (95%CI: 7-25). The study shows promising activity and manageable toxicity profile of BR combination as first-line therapy for patients with DLBCL who are prospectively defined as frail according to a simplified CGA, as adopted in this trial (clinicaltrials.gov identifier: 01990144)." @default.
• W2799290306 created "2018-05-17" @default.
• W2799290306 creator A5016803459 @default.
• W2799290306 creator A5017472528 @default.
• W2799290306 creator A5021455005 @default.
• W2799290306 creator A5026351398 @default.
• W2799290306 creator A5033613825 @default.
• W2799290306 creator A5039845542 @default.
• W2799290306 creator A5044126240 @default.
• W2799290306 creator A5054623894 @default.
• W2799290306 creator A5057722785 @default.
• W2799290306 creator A5061188476 @default.
• W2799290306 creator A5063235996 @default.
• W2799290306 creator A5063675719 @default.
• W2799290306 creator A5064203783 @default.
• W2799290306 creator A5066156769 @default.
• W2799290306 creator A5066201212 @default.
• W2799290306 creator A5069596141 @default.
• W2799290306 creator A5071466957 @default.
• W2799290306 creator A5074795646 @default.
• W2799290306 creator A5076114231 @default.
• W2799290306 creator A5079916873 @default.
• W2799290306 creator A5081879832 @default.
• W2799290306 creator A5084587855 @default.
• W2799290306 creator A5088159404 @default.
• W2799290306 creator A5089025495 @default.
• W2799290306 date "2018-05-10" @default.
• W2799290306 modified "2023-10-01" @default.
• W2799290306 title "Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>" @default.
• W2799290306 cites W1912693401 @default.
• W2799290306 cites W1965734230 @default.
• W2799290306 cites W1974084203 @default.
• W2799290306 cites W1987760772 @default.
• W2799290306 cites W2008108259 @default.
• W2799290306 cites W2022571127 @default.
• W2799290306 cites W2058015212 @default.
• W2799290306 cites W2077320602 @default.
• W2799290306 cites W2103099593 @default.
• W2799290306 cites W2116385028 @default.
• W2799290306 cites W2120373806 @default.
• W2799290306 cites W2124392008 @default.
• W2799290306 cites W2129827192 @default.
• W2799290306 cites W2131424155 @default.
• W2799290306 cites W2133201432 @default.
• W2799290306 cites W2136621779 @default.
• W2799290306 cites W2150129319 @default.
• W2799290306 cites W2153665789 @default.
• W2799290306 cites W2303933285 @default.
• W2799290306 cites W2487308472 @default.
• W2799290306 cites W2605767476 @default.
• W2799290306 doi "https://doi.org/10.3324/haematol.2017.186569" @default.
• W2799290306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6068040" @default.
• W2799290306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29748444" @default.
• W2799290306 hasPublicationYear "2018" @default.
• W2799290306 type Work @default.
• W2799290306 sameAs 2799290306 @default.
• W2799290306 citedByCount "38" @default.
• W2799290306 countsByYear W27992903062019 @default.
• W2799290306 countsByYear W27992903062020 @default.
• W2799290306 countsByYear W27992903062021 @default.
• W2799290306 countsByYear W27992903062022 @default.
• W2799290306 countsByYear W27992903062023 @default.
• W2799290306 crossrefType "journal-article" @default.
• W2799290306 hasAuthorship W2799290306A5016803459 @default.
• W2799290306 hasAuthorship W2799290306A5017472528 @default.
• W2799290306 hasAuthorship W2799290306A5021455005 @default.
• W2799290306 hasAuthorship W2799290306A5026351398 @default.
• W2799290306 hasAuthorship W2799290306A5033613825 @default.
• W2799290306 hasAuthorship W2799290306A5039845542 @default.
• W2799290306 hasAuthorship W2799290306A5044126240 @default.
• W2799290306 hasAuthorship W2799290306A5054623894 @default.
• W2799290306 hasAuthorship W2799290306A5057722785 @default.
• W2799290306 hasAuthorship W2799290306A5061188476 @default.
• W2799290306 hasAuthorship W2799290306A5063235996 @default.
• W2799290306 hasAuthorship W2799290306A5063675719 @default.
• W2799290306 hasAuthorship W2799290306A5064203783 @default.
• W2799290306 hasAuthorship W2799290306A5066156769 @default.
• W2799290306 hasAuthorship W2799290306A5066201212 @default.
• W2799290306 hasAuthorship W2799290306A5069596141 @default.
• W2799290306 hasAuthorship W2799290306A5071466957 @default.
• W2799290306 hasAuthorship W2799290306A5074795646 @default.
• W2799290306 hasAuthorship W2799290306A5076114231 @default.
• W2799290306 hasAuthorship W2799290306A5079916873 @default.
• W2799290306 hasAuthorship W2799290306A5081879832 @default.
• W2799290306 hasAuthorship W2799290306A5084587855 @default.
• W2799290306 hasAuthorship W2799290306A5088159404 @default.
• W2799290306 hasAuthorship W2799290306A5089025495 @default.
• W2799290306 hasBestOaLocation W27992903061 @default.
• W2799290306 hasConcept C126322002 @default.
• W2799290306 hasConcept C141071460 @default.
• W2799290306 hasConcept C197934379 @default.
• W2799290306 hasConcept C2776694085 @default.
• W2799290306 hasConcept C2777063308 @default.
• W2799290306 hasConcept C2778559949 @default.
• W2799290306 hasConcept C2779338263 @default.
• W2799290306 hasConcept C2780653079 @default.
• W2799290306 hasConcept C2781442060 @default.
• W2799290306 hasConcept C31760486 @default.

• next